|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 1717 PENNSYLVANIA AVENUE, NW |
Address2 |
|
| City | WASHINGTON |
State | DC |
Zip Code | 20006 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 24806-12
|
||||||||
|
6. House ID# 336110000
|
||||||||
| TYPE OF REPORT | 8. Year | 2024 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Anders Gilberg |
Date | 7/30/2024 4:15:02 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Medicare Payment - Submitted response to the Senate Committee on Finances White Paper, Bolstering Chronic Care through Physician Payment: Current Challenges and Policy Options in Medicare Part B; submitted testimony for House Committee on Ways and Means Subcommittee on Healths hearing, The Collapse of Private Practice: Examining the Challenges Facing Independent Medicine; Submitted testimony for Senate Committee on Finances hearing, Rural Health Care: Supporting Lives and Improving Communities; Submitted testimony to Senate Committee on Finances hearing, Bolstering Chronic Care through Medicare Physician Payment.
Value-Based Care - Submitted testimony for House Committee on Energy and Commerce Subcommittee on Healths hearing, Checking-In on CMMI: Assessing the Transition to Value-Based Care.
Change Healthcare Cyberattack - Sent two letters requesting guidance from OCR about the Change Healthcare cyberattack and HIPAA breach notifications; Joined two letters to OCR on the Change Healthcare cyberattack and implications to medical groups; Submitted testimony for Senate Committee on Finances hearing, Hacking Americas Health Care: Assessing the Change Healthcare Cyber Attack and Whats Next; Submitted testimony for House Committee on Energy and Commerces hearing, Examining Health Sector Cybersecurity in the Wake of the Change Healthcare Attack.
Prior Authorization - Supported the reintroduction of the Improving Seniors Timely Access to Care Act; Submitted letter to CMS on its proposed prior authorization demonstration project for certain ambulatory surgical center services.
Medicare Advantage - Responded to CMS RFI on Medicare Advantage data.
Administrative Burden in Healthcare - Submitted testimony to Senate Budget Committees hearing, Reducing Paperwork, Cutting Costs: Alleviating Administrative Burdens in Health Care.
Patient Matching - Joined letter to Congress supporting the repeal of Section 510 of the Labor-HHS Appropriations bill that prohibits spending on adopting a national unique patient ID standard.
Telehealth - Submitted testimony to House Committee on Energy and Commerces hearing, Legislative Proposals to Support Patient Access to Telehealth Services; Joined letter asking DEA to expedite release of telehealth rule for prescribing controlled medications.
Graduate Medical Education - Joined letter to Senate Finance Committee with recommendations on graduate medical education.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Drug Enforcement Administration (DEA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Anders |
Gilberg |
|
|
|
James |
Haynes |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Medicare Payment - Submitted response to the Senate Committee on Finances White Paper, Bolstering Chronic Care through Physician Payment: Current Challenges and Policy Options in Medicare Part B; submitted testimony for House Committee on Ways and Means Subcommittee on Healths hearing, The Collapse of Private Practice: Examining the Challenges Facing Independent Medicine; Submitted testimony for Senate Committee on Finances hearing, Rural Health Care: Supporting Lives and Improving Communities; Submitted testimony to Senate Committee on Finances hearing, Bolstering Chronic Care through Medicare Physician Payment.
Value-Based Care - Submitted testimony for House Committee on Energy and Commerce Subcommittee on Healths hearing, Checking-In on CMMI: Assessing the Transition to Value-Based Care.
Change Healthcare Cyberattack - Sent two letters requesting guidance from OCR about the Change Healthcare cyberattack and HIPAA breach notifications; Joined two letters to OCR on the Change Healthcare cyberattack and implications to medical groups; Submitted testimony for Senate Committee on Finances hearing, Hacking Americas Health Care: Assessing the Change Healthcare Cyber Attack and Whats Next; Submitted testimony for House Committee on Energy and Commerces hearing, Examining Health Sector Cybersecurity in the Wake of the Change Healthcare Attack.
Prior Authorization - Supported the reintroduction of the Improving Seniors Timely Access to Care Act; Submitted letter to CMS on its proposed prior authorization demonstration project for certain ambulatory surgical center services.
Medicare Advantage - Responded to CMS RFI on Medicare Advantage data.
Administrative Burden in Healthcare - Submitted testimony to Senate Budget Committees hearing, Reducing Paperwork, Cutting Costs: Alleviating Administrative Burdens in Health Care.
Patient Matching - Joined letter to Congress supporting the repeal of Section 510 of the Labor-HHS Appropriations bill that prohibits spending on adopting a national unique patient ID standard.
Telehealth - Submitted testimony to House Committee on Energy and Commerces hearing, Legislative Proposals to Support Patient Access to Telehealth Services; Joined letter asking DEA to expedite release of telehealth rule for prescribing controlled medications.
Graduate Medical Education - Joined letter to Senate Finance Committee with recommendations on graduate medical education.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Anders |
Gilberg |
|
|
|
James |
Haynes |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |